(±) -Lisofylline-d4

CAT: 0804-HY-126042S4Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-126042S4Size:1 Each
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
(±) -Lisofylline-d4 ((±) -Lisophylline-d4) is deuterium labeled (±) -Lisofylline. (±) -Lisofylline ((±) -Lisophylline) is the racemate of Lisofylline. Lisofylline inhibits the generation of phosphatidic acid and free fatty acids. Lisofylline also blocks the release of pro-inflammatory cytokines in oxidative tissue injury, in response to cancer chemotherapy and in experimental sepsis. Lisofylline can be used for Type 1 diabetes research[1].
CAS Number
[1185879-05-3]
Product Name Alternative
(±) -Lisophylline-d4
UNSPSC
12352005
Target
Interleukin Related; Isotope-Labeled Compounds
Related Pathways
Immunology/Inflammation; Others
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease; Inflammation/Immunology
Smiles
O=C1C2=C(N=CN2C([2H])([2H])[2H])N(C(N1CCCCC(O)([2H])C)=O)C
Molecular Formula
C13H16D4N4O3
Molecular Weight
284.35
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Yang Z, et al. Lisofylline: a potential lead for the treatment of diabetes. Biochem Pharmacol. 2005 Jan 1;69 (1) :1-5.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported